| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Personal Finance > A Simple Solution For Maximizing The Power of Your Money |
|
Just Answers - A Simple Solution For Maximizing The Power of Your Money
In today’s world, people can barely count on their fingers the number of different financial accounts that they have: loans for According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product school, emergency funds, investment funds, mortgage - the list could go on and on. With so many accounts to put your money in, ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t can be hard to know exactly what to do. The good news is that there is a simple principle for maximizing the power of your mo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ney across all your financial accounts and it amounts to moving your money out of low-interest accounts and itno high-interest a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe counts. The first step is to make a list of all your accounts along with their interest rates (either positive or negative). H d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro pothetically, let’s say that you’ve got a total of $6,000 in credit card debt at 15% interest. You’ve also got a $125,000 mortg ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc age at 6.5% interest. Other accounts might include a savings account with $25,000 making 3% interest, and a retirement account easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ith $40,000 making 10% interest. Most people probably have more than four accounts. In fact, if you are like the average Ameri nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically an, it is more likely that you have upwards of 10-15 accounts. Ok. So we have four accounts. The question that we need to ask and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ is whether our money is being used in the best way across these accounts? In other words, are we currently maximizing the power ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi of our money? It turns out that we are not. The main reason is that there is too much money wrapped up in the low-interest sav ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ng account. What you need to do is move the money out of your savings account and put it into those accounts with the highest i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nterest rates (both positive and negative). In this case, the highest interest rates are the credit cards. Once we’ve paid the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin credit card accounts, we’d still have $19,000 left in savings: still far too much for such a low-interest account. In its curre tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t state, the money in the savings account is not being used effectively. The next step is to look for the account with the next t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel highest interest rates. This account turns out to be your retirement account at 10% interest. Don’t be tempted here to pay do ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust n your mortgage! You’ll be losing out on tax benefits plus close to 3.5% interest per year. Once you’ve maxed out your retirem y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nt contributions, go onto the account with the next highest interst rate, and so on until you’ve distributed your money into the . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de accounts with the highest interest rates. You can always maximize the power of your money by letting it flow into accounts wit elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the highest interest rates. By using this simple principle, you can maximize the power of your money in today’s modern economy tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Get Relief from Debts with a Bad Credit Home Loan
|